background
pandem
influenza
viru
spread
worldwid
infect
larg
proport
human
popul
discoveri
new
effect
drug
treatment
influenza
crucial
issu
global
medic
commun
accord
previou
studi
fraction
aqueou
extract
tender
leaf
toonasinensi
demonstr
antivir
activ
pandem
influenza
downregul
adhes
molecul
chemokin
prevent
viral
attach
method
aim
present
studi
identifi
activ
compound
exert
antiinfluenza
viru
effect
xtt
assay
use
detect
cell
viabil
meanwhil
inhibitori
effect
pandem
influenza
viru
analyz
observ
plaqu
format
qrtpcr
neuraminidas
activ
immunofluoresc
stain
influenza
aspecif
glycoprotein
result
catechin
gallic
acid
found
potent
inhibitor
term
influenza
viru
mrna
replic
mdck
plaqu
format
addit
compound
inhibit
neuraminidas
activ
viral
glycoprotein
effect
inhibit
concentr
ec
catechin
gallic
acid
influenza
viru
mgml
mgml
respect
wherea
cytotox
concentr
cc
catechin
gallic
acid
mgml
mgml
respect
thu
select
index
si
catechin
gallic
acid
respect
conclus
present
studi
demonstr
catechin
might
safe
reagent
longterm
use
prevent
influenza
viru
infect
wherea
gallic
acid
might
sensit
reagent
inhibit
influenza
viru
infect
conclud
two
phytochem
respons
exert
antipandem
influenza
viru
effect
april
novel
pandem
influenza
viru
identifi
mexico
quickli
spread
throughout
world
extens
morbid
unaccept
mortal
rate
influenza
viru
present
global
health
threat
associ
high
risk
sever
complic
sinc
viru
circul
within
also
numer
host
conflict
interest
author
declar
conflict
interest
relat
subject
matter
materi
discuss
articl
popul
viru
transmit
mainli
cough
sneez
close
bodili
contact
thu
far
vaccin
major
resolut
strategi
control
season
influenza
viral
pandem
present
two
major
class
antivir
drug
oseltamivir
amantadin
commonli
use
prophylaxi
treatment
influenza
viru
infect
oseltamivir
neuraminidas
inhibitor
inhibit
spread
viru
releas
viru
progeni
infect
cell
amantadin
block
protein
order
inhibit
viral
uncoat
infect
cell
drug
target
highli
variabl
sequenc
consequ
viru
easili
acquir
resist
mutat
drug
target
recent
increas
resist
influenza
virus
amantadin
oseltamivir
report
discoveri
new
effect
drug
prevent
andor
treat
influenza
infect
crucial
challeng
global
medic
commun
natur
product
deriv
tradit
chines
medicin
found
exert
antivir
effect
influenza
viru
tender
leav
toonasinensi
ts
commonli
regard
nutrit
supplement
veget
common
consumpt
taiwan
report
ts
extract
use
treat
variou
diseas
shown
varieti
effect
includ
glycem
control
inhibit
lipid
accumul
antimicrobi
activ
anticanc
mani
compound
includ
retinoid
catechin
gallic
acid
kaempferol
methyl
gallat
quercetin
afzelin
quercitrin
isoquercitrin
rutin
isol
leav
ts
accord
previou
studi
verifi
inhibit
attach
activ
toward
pandem
influenza
downregul
adhes
molecul
prevent
viru
infect
yet
unclear
major
compound
execut
antiinfluenza
viru
activ
aim
studi
evalu
chemic
compound
present
includ
catechin
gallic
acid
kaempferol
quercetin
rutin
examin
inhibit
pandem
influenza
viru
replic
cell
model
herein
character
antiinfluenza
viral
activ
two
major
compound
present
catechin
gallic
acid
catechin
rutin
trihydr
purchas
fluka
st
loui
mo
usa
three
compound
includ
gallic
acid
kaempferol
quercetin
hydrat
purchas
sigmaealdrich
chemic
compani
st
loui
mo
usa
chemic
dissolv
dmso
final
stock
concentr
mm
store
c
compound
serial
dilut
variou
concentr
use
complet
mem
madin
darbi
canin
kidney
mdck
cell
human
lung
carcinoma
cell
purchas
atcc
manassa
va
usa
cell
line
propag
mem
medium
invitrogen
life
technolog
carlsbad
ca
usa
supplement
heatedinactiv
fb
ngml
amphotericin
b
mgml
penicillinstreptomycin
invitrogen
life
technolog
carlsbad
ca
usa
pandem
influenza
viru
isol
outbreak
obtain
clinic
virolog
laboratori
kaohsiung
chang
gung
memori
hospit
taiwan
viru
propag
mdck
cell
assess
plaqu
titrat
viral
stock
prepar
describ
elsewher
viru
titer
determin
cytopath
effect
cpe
express
tissu
cultur
infect
dose
cytotox
effect
chemic
compound
prolifer
cell
determin
plate
use
xtt
assay
tetrazolium
hydroxid
salt
accord
manufactur
instruct
roch
molecular
diagnost
germani
briefli
cell
cellswel
plate
incub
period
h
variou
concentr
mgml
chemic
compound
supplement
immedi
incub
c
co
day
xtt
reagent
ad
incub
h
absorb
result
solut
measur
spectrophotometr
nm
sunris
tecan
refer
nm
experi
carri
triplic
perform
least
thrice
separ
cytotox
concentr
chemic
compound
reduc
cell
viabil
cc
calcul
regress
analysi
dose
respons
curv
gener
data
untreat
control
set
monolay
cell
concentr
cell
ml
infect
pandem
influenza
viru
multipl
infect
moi
h
solut
remov
cell
wash
twice
phosphat
buffer
salin
pb
supplement
growth
media
contain
five
chemic
compound
differ
concentr
amantadin
use
posit
control
cell
harvest
h
afterinfect
viral
yield
estim
quantit
revers
transcriptionpolymeras
chain
reaction
qrtpcr
neuraminidas
activ
assay
plaqu
assay
mdck
cell
vehicl
control
infect
cell
incub
chemicalfre
medium
includ
throughout
experi
monolay
cell
concentr
cell
ml
infect
pandem
influenza
viru
moi
h
replac
medium
contain
chemic
compound
variou
concentr
virus
harvest
h
postinfect
use
process
three
cycl
freez
thaw
clarifi
low
speed
centrifug
g
min
viru
yield
cultur
supernat
assay
standard
plaqu
assay
mdck
cell
determin
actual
infecti
viral
titer
briefli
confluent
monolay
mdck
cell
cultur
tissu
cultur
plate
cellscm
infect
supernat
min
viru
incub
inoculum
remov
replac
overlay
medium
mem
contain
mgml
trypsin
low
melt
agaros
without
serum
contain
chemic
compound
differ
concentr
incub
cultur
h
c
co
monolay
fix
formaldehyd
solut
min
agaros
remov
flow
water
stain
wv
crystal
violet
solut
assay
perform
plate
triplic
viral
titer
determin
count
number
plaqu
viru
plaqu
count
quantiti
one
version
biorad
laboratori
examin
percentag
plaqu
inhibit
calcul
rel
untreat
control
requir
concentr
reduc
plaqu
number
ec
calcul
regress
analysi
doseerespons
curv
gener
data
monolay
cell
concentr
cellsml
infect
pandem
influenza
viru
moi
h
solut
remov
cell
wash
twice
pb
supplement
growth
media
contain
chemic
compound
differ
concentr
amantadin
use
posit
control
cell
harvest
h
postinfect
viral
yield
estim
qrtpcr
vehicl
control
infect
cell
incub
chemicalfre
medium
includ
throughout
experi
total
nucleic
acid
extract
use
high
pure
rna
kit
roch
molecular
diagnost
germani
follow
manufactur
instruct
qrtpcr
assay
perform
use
standard
precaut
avoid
contamin
quantif
rtpcr
perform
use
taqman
fast
kit
invitrogen
san
diego
ca
primer
previous
describ
follow
treatment
procedur
experi
na
activ
assay
perform
accord
manufactur
instruct
use
neuraminidas
activ
assay
kit
abcam
ca
usa
reaction
monitor
use
spectromet
kinet
mode
excit
wavelength
nm
emiss
wavelength
nm
cell
cellsml
grown
tissu
cultur
slide
cultur
c
h
cell
wash
pb
infect
pandem
influenza
viru
moi
h
solut
remov
cell
wash
twice
pb
supplement
growth
media
contain
either
catechin
gallic
acid
differ
concentr
incub
cultur
h
c
co
cell
wash
pb
three
time
fix
aceton
block
fix
cell
incub
fitc
conjug
antiinfluenza
monoclon
antibodi
conjunct
evan
blue
contrast
stain
oxoid
hampshir
uk
cell
count
perform
use
fluoresc
microscop
olympu
tokyo
japan
data
present
mean
standard
deviat
sd
data
statist
evalu
use
either
student
ttest
analysi
varianc
anova
level
p
consid
statist
signific
cytotox
effect
pandem
influenza
viru
five
chemic
compound
screen
xtt
method
viabil
shown
percent
compar
control
cell
without
treatment
cell
infect
viru
moi
media
absenc
presenc
chemic
period
day
cell
viabil
measur
treatment
xtt
h
amantadin
mgml
use
posit
control
shown
fig
cc
five
compound
cc
catechin
fig
kaempferol
fig
quercetin
hydrat
fig
rutintrihydr
fig
mgml
cc
gallic
acid
fig
mgml
ec
catechin
might
around
mgml
fig
ec
gallic
acid
around
mgml
fig
result
demonstr
catechin
gallic
acid
exert
protect
effect
pandem
influenza
viru
infect
dosedepend
manner
mgml
mgml
treatment
respect
three
compound
also
protect
effect
pandem
influenza
viru
promin
dosedepend
comparison
catechin
gallic
acid
base
find
select
catechin
gallic
acid
investig
evalu
antipandem
influenza
viru
activ
employ
plaqu
assay
test
vitro
effect
catechin
gallic
acid
viral
replic
found
two
compound
exhibit
inhibitori
effect
pandem
influenza
viral
infect
dosedepend
manner
result
plaqu
assay
show
approxim
reduct
pandem
influenza
viral
product
upon
treatment
mg
ml
catechin
ec
mgml
mgml
gallic
acid
ec
mgml
shown
fig
cell
infect
pandem
influenza
viru
incub
h
presenc
variou
concentr
catechin
gallic
acid
total
rna
isol
infect
cell
qrtpcr
analysi
perform
use
specif
primer
viral
gene
rna
inhibitori
effect
viral
genom
load
infect
shown
copi
number
decrement
treatment
calcul
absolut
quantif
illustr
fig
catechin
gallic
acid
significantli
reduc
number
infect
cell
moi
qrtpcr
result
demonstr
signific
inhibit
viral
rna
synthesi
infect
cell
concentr
greater
mgml
catechin
fig
mgml
gallic
acid
fig
treatment
comparison
control
group
na
key
viral
protein
respons
releas
newli
produc
viru
particl
recognit
cleavag
target
cell
receptor
sialic
acid
moieti
nacetylneuramin
acid
infect
cell
perform
na
assay
explor
whether
catechin
gallic
acid
inhibit
viru
replic
target
na
activ
virusonli
control
show
na
activ
promin
howev
na
activ
significantli
reduc
presenc
two
chemic
compar
vehicl
control
fig
b
result
suggest
catechin
gallic
acid
inhibitori
effect
releas
step
pandem
influenza
viru
na
inactiv
investig
whether
catechin
gallic
acid
could
affect
infect
cell
viru
immunofluoresc
stain
assay
influenza
viru
glycoprotein
perform
normal
cell
show
red
color
fig
extens
specif
green
fluoresc
observ
viru
control
cell
fig
howev
green
fluoresc
decreas
dosedepend
manner
cell
treat
catechin
fig
gallic
acid
fig
overal
catechin
gallic
acid
exhibit
obviou
antiinfluenza
viru
activ
shown
fig
summar
antiviru
effect
five
compound
growth
influenza
viru
particl
estim
dose
reduc
cell
viabil
shown
tabl
cytotox
concentr
cc
chemic
compound
calcul
select
index
si
defin
ratio
cc
ec
indic
therapeut
safeti
result
analysi
show
five
chemic
analyz
catechin
kaemperol
quercetin
rutin
lowest
toxic
howev
catechin
demonstr
antivir
infect
effect
ec
mgml
three
chemic
applic
gallic
acid
also
exert
effect
pandem
influenza
viral
infect
ec
mgml
cc
gallic
acid
mg
ml
indic
gallic
acid
highest
toxic
mdck
cell
infect
pandem
influenza
viru
si
influenza
virus
gener
infect
approxim
global
popul
annual
associ
approxim
death
year
influenza
viru
novel
highli
contagi
pathogen
human
associ
high
risk
sever
complic
first
identifi
mexico
caus
season
epidem
pandem
oseltamivir
tamiflu
zanamivir
relenza
approv
use
type
type
b
influenza
infect
howev
develop
drug
resist
due
use
insuffici
dose
inadequ
cours
therapi
may
limit
futur
clinic
applic
drug
base
limit
health
care
resourc
high
cost
current
antivir
drug
addit
develop
drug
resist
need
develop
new
antiinfluenza
treatment
utmost
import
global
commun
chines
herb
tradit
use
prevent
treat
influenza
taiwan
especi
rural
region
recent
isatisindigotica
banlangen
report
effectli
inhibit
attach
abil
influenza
b
virus
interf
viral
particl
host
cell
surfac
paeonialactiflora
also
demonstr
inhibit
influenza
infect
vitro
vivo
viral
hemagglutin
viral
bind
penetr
host
cell
furthermor
mosladianthera
exhibit
therapeut
effect
influenza
virusinfect
mice
suppress
viral
replic
inflammatori
mediat
boost
antioxid
potenti
prevent
subsequ
pneumonia
occurr
fraction
aqueou
extract
tender
leaf
ts
veget
commonli
consum
taiwanes
daili
life
previou
studi
found
effect
inhibit
coronaviru
lifethreaten
highli
contagi
viru
induc
sever
acut
respiratori
syndrom
sar
meanwhil
inhibit
influenza
viru
attach
signific
downregul
adhes
molecul
chemokin
includ
eselectin
fractalkin
aqueou
extract
ts
character
hplc
nine
compound
present
ts
gallic
acid
methyl
gallat
catechin
kaempferol
kaempferol
quercetin
quercitrin
fig
catechin
gallic
acid
inhibit
influenza
viru
propag
pandem
influenza
viru
moi
inocul
cell
h
virus
remov
cell
treat
catechin
mgml
b
gallic
acid
mgml
individu
cultur
incub
day
c
co
yield
progeni
virus
cell
determin
plaqu
titrat
assay
mdck
cell
concentr
chemic
analyz
triplic
result
repres
mean
sd
three
independ
assay
asterisk
indic
signific
differ
p
compar
vehicl
control
respect
fig
cytotox
assay
five
chemic
compound
cell
infect
without
viru
moi
variou
concentr
chemic
compound
cell
viabil
measur
day
use
xtt
viabil
assay
five
chemic
compound
includ
catechin
b
gallic
acid
c
kaempferol
quercetin
e
rutin
normal
rel
viabil
untreat
cell
set
result
repres
mean
sd
three
independ
assay
asterisk
pound
indic
signific
differ
p
compar
control
group
without
treatment
viru
infect
respect
quercetin
rutin
previous
report
exert
posit
effect
term
diseas
treatment
thu
chose
major
five
compound
catechin
gallic
acid
kaempferol
quercetin
rutin
commerci
avail
investig
antiinfluenza
viru
effect
analys
found
catechin
gallic
acid
protect
effect
present
studi
demonstr
gallic
acid
effect
inhibit
influenza
viru
toxic
cell
comparison
catechin
catechin
demonstr
inhibitori
effect
influenza
viru
also
promis
term
safeti
three
major
compound
either
cytotox
cell
offer
less
protect
effect
influenza
viru
infect
catechin
major
chemic
compound
present
green
tea
one
wide
consum
beverag
world
provid
varieti
health
benefit
studi
report
green
tea
catechin
sever
antiinfluenza
viru
activ
vivo
vitro
matsumoto
et
al
found
consum
catechintheanin
fig
antivir
assay
catechin
gallic
acid
cell
infect
pandem
influenza
viru
h
virus
remov
cell
treat
catechin
mgml
b
gallic
acid
mgml
untreat
vehicl
control
total
rna
extract
perform
day
influenza
viru
infect
level
intracellular
influenza
viral
rna
replic
measur
qrtpcr
concentr
chemic
assay
triplic
result
repres
mean
sd
three
independ
assay
asterisk
indic
signific
differ
p
compar
vehicl
control
respect
month
statist
signific
prevent
effect
clinic
defin
influenza
infect
welltoler
conclud
green
tea
may
effect
prophylaxi
influenza
infect
furthermor
clinic
trial
yamada
et
al
shown
gargl
tea
contain
catechin
extract
effect
prevent
influenza
viru
infect
elderli
nurs
home
resid
catechin
assess
term
abil
interact
influenza
neuraminidas
significantli
suppress
increas
ro
level
prevent
influenza
infect
gallic
acid
easi
extract
number
plant
fruit
tea
clove
gallic
acid
reportedli
potent
broad
antivir
activ
influenza
b
type
virus
vitro
vivo
theisen
et
al
report
cytotox
antivir
activ
viru
apuerto
gallic
acid
cc
ec
si
mm
mm
mm
respect
differ
result
report
present
studi
could
possibl
result
differ
viral
strain
use
experiment
addit
therapeut
safeti
gallic
acid
found
lower
hydrolys
tannin
pseudotannin
studi
found
two
compound
inde
exert
antiinfluenza
viru
replic
via
signific
inhibit
viral
rna
synthesi
meanwhil
catechin
gallic
acid
shown
inhibit
growth
pandem
influenza
mgml
mgml
mdck
cell
si
respect
indic
catechin
might
safe
reagent
longterm
use
prevent
influenza
viru
infect
wherea
gallic
acid
might
sensit
reagent
inhibit
influenza
viru
infect
promis
candid
protect
host
pandem
influenza
viru
therefor
may
use
food
supplement
adjunct
therapi
current
drug
prevent
influenza
viru
infect
fig
measur
antivir
activ
catechin
gallic
acid
use
neuraminidas
activ
assay
cell
infect
pandem
influenza
viru
h
virus
remov
cell
treat
catechin
mgml
b
gallic
acid
mgml
fluoresc
monitor
excit
wavelength
nm
emiss
wavelength
nm
experi
repeat
three
time
independ
differ
shown
p
significantli
conclus
studi
provid
evid
support
catechin
gallic
acid
inhibit
pandem
influenza
viru
activ
catechin
promis
lowtox
abundantli
avail
treatment
prevent
influenza
infect
furthermor
gallic
acid
offer
potenti
develop
new
drug
due
signific
antiinfluenza
viru
effect
less
cytotox
effect
low
dose
host
cell
howev
specif
character
activ
compound
mechan
provid
protect
effect
influenza
viru
infect
requir
investig
present
catechin
gallic
acid
may
provid
effect
altern
replac
supplement
current
avail
antiinfluenza
remedi
